Companies · Other Health Care

Mri Interventions, Inc.

SOLANA BEACH · Other Health Care

Diligence memoA one-page analyst read on Mri Interventions, Inc. — recommendation, valuation, rhythm, risks.
$90.0M
Total raised · real
13
Rounds
2.4×
Latest step-up
Top 6%
Sector rank · raised
Series B
Latest stage · inferred · Thu Nov 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Mri Interventions, Inc. looks fair against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.83× the median modeled value of Series B Other Health Care companies in 2025–2027 (48 peers) — value vs value, same stage and era.
  • Within the normal band (83% of peer median) for its niche.
Active
  • Last raise 7 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Mri Interventions, Inc. is one of 5376 Other Health Care companies tracked from SOLANA BEACH. By capital raised it ranks among the largest (ahead of 95% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
46
Investors (latest)
2025-11-20
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeed · 2009-10-16 Raised $2.0M (real) Modeled valuation $50M (est)Seed2009Series A · 2010-07-01 Raised $4.6M (real) Modeled valuation $93M (est)Series A2010Seed · 2010-07-01 Raised $3.0M (real) Modeled valuation $74M (est)Seed2010Series A · 2011-06-30 Raised $1.3M (real) Modeled valuation $26M (est)Series A2011Pre-Seed · 2011-06-30 Raised $500K (real) Modeled valuation $15M (est)Pre-Seed2011Series A · 2011-10-14 Raised $150K (real) Modeled valuation $3.0M (est)Series A2011Series A · 2012-07-02 Raised $6.0M (real) Modeled valuation $121M (est)Series A2012Series A · 2013-01-25 Raised $11M (real) Modeled valuation $223M (est)Series A2013Series A · 2014-03-25 Raised $3.7M (real) Modeled valuation $75M (est)Series A2014Series A · 2014-07-01 Raised $7.5M (real) Modeled valuation $151M (est)Series A2014Series A · 2014-12-09 Raised $10M (real) Modeled valuation $205M (est)Series A2014Series A · 2015-12-18 Raised $5.3M (real) Modeled valuation $107M (est)Series A2015Series A · 2016-09-02 Raised $6.0M (real) Modeled valuation $121M (est)Series A2016Series A · 2017-05-26 Raised $13M (real) Modeled valuation $267M (est)Series A2017Series A · 2019-05-17 Raised $7.5M (real) Modeled valuation $152M (est)Series A2019Series B · 2025-11-20 Raised $18M (real) Modeled valuation $77M (est)Series B2025Cumulative $100M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.0M · 2009
Series A$4.6M · 2010
Bridge · Series A-stage$3.0M · 2010smaller follow-on
Series A extension$1.3M · 2011
Bridge · Series A-stage$500K · 2011smaller follow-on
Series A extension$150K · 2011
Series A extension$6.0M · 2012
Series A extension$11.0M · 2013
Series A extension$3.7M · 2014
Series A extension$7.5M · 2014
Series A extension$10.2M · 2014
Series A extension$5.3M · 2015
Series A extension$6.0M · 2016
Series A extension$13.3M · 2017
Series A extension$7.5M · 2019
Series B$17.9M · 2025

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$76.6M
Base estimate est.
$42.0M
Conservative case
$105.0M
Upside case
$99.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $49.6M · 2009-10-162009Series A · modeled $92.8M · 2010-07-01Seed · modeled $74.4M · 2010-07-01Series A · modeled $26.4M · 2011-06-30Pre-Seed · modeled $15.4M · 2011-06-30Series A · modeled $3.0M · 2011-10-14Series A · modeled $121.1M · 2012-07-02Series A · modeled $222.8M · 2013-01-25Series A · modeled $75.2M · 2014-03-25Series A · modeled $151.3M · 2014-07-01Series A · modeled $205.3M · 2014-12-09Series A · modeled $106.8M · 2015-12-18Series A · modeled $121.2M · 2016-09-02Series A · modeled $267.4M · 2017-05-26Series A · modeled $151.8M · 2019-05-17Series B · modeled $76.6M · 2025-11-202025
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
0.6 yr
Elapsed time used
0.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
13 mo
Avg between rounds
$5.6M/yr
Capital velocity
16.7 yr
On record since
2009
First round
16
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 37× above median
This company$90.0M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.0× above median
This company$17.9M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 3.5× above median
This company$76.6M
Sector median$22.1M

Raised more than 95% of sector peers (real $). Modeled value above 74% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #29 of 48.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)Imagine Pediatrics Holdings LLC · Series B Raised $37.6M · modeled $201.0M (est)Porter Cares, Inc. · Series B Raised $48.5M · modeled $183.7M (est)True Medicine Inc. · Series B Raised $42.7M · modeled $175.7M (est)CranioVation, Inc. · Series B Raised $56.7M · modeled $174.9M (est)Seriously Clean LTD. · Series B Raised $32.5M · modeled $166.2M (est)Reprieve Cardiovascular, Inc. · Series B Raised $82.4M · modeled $152.9M (est)CODAN US Holding Corp · Series B Raised $27.8M · modeled $144.5M (est)CODAN US Corp · Series B Raised $27.7M · modeled $144.1M (est)Conceivable Life Sciences Inc. · Series B Raised $63.5M · modeled $142.7M (est)KeyCare, Inc. · Series B Raised $54.4M · modeled $142.6M (est)Particle Dynamics Holdings, Inc. · Series B Raised $30.9M · modeled $140.5M (est)EvolvedMD, Inc. · Series B Raised $49.0M · modeled $139.0M (est)Mri Interventions, Inc. (this company) Raised $90.0M · modeled $76.6M (est)Mri Interventions, Inc.
CompanyStageRaised · realValue · estvs peer med.
Imagine Pediatrics Holdings LLCSeries B$37.6M$201.0M2.18×
Porter Cares, Inc.Series B$48.5M$183.7M2.00×
True Medicine Inc.Series B$42.7M$175.7M1.91×
CranioVation, Inc.Series B$56.7M$174.9M1.90×
Seriously Clean LTD.Series B$32.5M$166.2M1.81×
Reprieve Cardiovascular, Inc.Series B$82.4M$152.9M1.66×
CODAN US Holding CorpSeries B$27.8M$144.5M1.57×
CODAN US CorpSeries B$27.7M$144.1M1.57×
Conceivable Life Sciences Inc.Series B$63.5M$142.7M1.55×
KeyCare, Inc.Series B$54.4M$142.6M1.55×
Particle Dynamics Holdings, Inc.Series B$30.9M$140.5M1.53×
EvolvedMD, Inc.Series B$49.0M$139.0M1.51×
Mri Interventions, Inc. this companySeries B$90.0M$76.6M0.83×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.0M2009-10-16$10.0M$49.6M85%
Series A$4.6M2010-07-01$20.9M$92.8M85%
Seed$3.0M2010-07-01$15.0M$74.4M85%
Series A$1.3M2011-06-30$6.0M$26.4M85%
Pre-Seed$500K2011-06-30$2.8M$15.4M85%
Series A$150K2011-10-14$682K$3.0M85%
Series A$6.0M2012-07-02$27.3M$121.1M85%
Series A$11.0M2013-01-25$50.2M$222.8M85%
Series A$3.7M2014-03-25$16.9M$75.2M85%
Series A$7.5M2014-07-01$34.1M$151.3M85%
Series A$10.2M2014-12-09$46.3M$205.3M85%
Series A$5.3M2015-12-18$24.1M$106.8M85%
Series A$6.0M2016-09-02$27.3M$121.2M85%
Series A$13.3M2017-05-26$60.2M$267.4M90%
Series A$7.5M2019-05-17$34.2M$151.8M90%
Series B$17.9M2025-11-20$99.4M$76.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.0M2009-10-16
    • First recorded raise — entered as Seed.
    • 1 investor on this round.
  2. Series A$4.6M2010-07-01
    • Raised 8 mo later, in step with the ~14 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
  3. Seed$3.0M2010-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
  4. Series A$1.3M2011-06-30
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.3× smaller than the prior — bridge or down round.
    • 6 investors on this round.
  5. Pre-Seed$500K2011-06-30
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.6× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  6. Series A$150K2011-10-14
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 3.3× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  7. Series A$6.0M2012-07-02
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 40.0× larger than the prior — scaling up.
    • 65 investors on this round.
  8. Series A$11.0M2013-01-25
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 1.8× larger than the prior — scaling up.
    • 47 investors on this round.
  9. Series A$3.7M2014-03-25
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round 3.0× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 10 investors on this round.
  10. Series A$7.5M2014-07-01
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 2.0× larger than the prior — scaling up.
  11. Series A$10.2M2014-12-09
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 1.4× larger than the prior — scaling up.
    • 74 investors on this round.
  12. Series A$5.3M2015-12-18
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.9× smaller than the prior — bridge or down round.
    • 57 investors on this round.
  13. Series A$6.0M2016-09-02
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 24 investors on this round.
  14. Series A$13.3M2017-05-26
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 2.2× larger than the prior — scaling up.
    • 60 investors on this round.
  15. Series A$7.5M2019-05-17
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 1.8× smaller than the prior — bridge or down round.
    • 17 investors on this round.
  16. Series B$17.9M2025-11-20
    • Raised again after 78 mo — slower than the ~14 mo sector norm.
    • Round 2.4× larger than the prior — scaling up.
    • 46 investors on this round.
Intelligence
2026 ~Q4
Modeled next raise · ~13mo cadence
$42.6M
Modeled next size est.range $27.7M$68.1M
2.4×
Last step-up
$5.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
B. KRISTINE JOHNSON4 other2025-11
Parker H. Petit4 other2009-10
R. John Fletcher3 other2017-05
Charles E. Koob2 other2011-06
Pascal E.R. Girin2 other2014-12
Andrew K Rooke1 other2011-06
Bruce C. Conway1 other2011-06
Charles L. Koob1 other2009-10
Francis P. Grillo1 other2014-12
John N. Spencer, Jr.1 other2010-07
Matthew B. Klein1 other2025-11
Carol J. Barbre2012-07
Danilo T. D'Alessandro2025-11
David W. Carlson2010-07
Harold A. Hurwitz2015-12
James K Malernee, Jr.2010-07
Jenkins L. Kimble2014-12
Jeremy L. Stigall2025-11
John L. Thomas2009-10
Joseph M. Burnett2019-05
Kimble L. Jenkins2009-10
Lenox L. Baker2009-10
Linda M. Liau2025-11
Lynnette C. Fallon2025-11
Registry & provenance

Mri Interventions, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1285550
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Respicardia, Inc.Other Health CareSeries B$92.4M$443.1Mnetwork1 shared operator · same sector · same stage
Metabolon, IncOther Health CareSeries B$123.6M$42.1Mnetwork1 shared operator · same sector · same stage
ev3 Inc.Other Health CareSeries B$34.6M$767.6Mnetwork1 shared operator · same sector · same stage
DemeRx, Inc.PharmaceuticalsSeries A$28.7M$9.0Mnetwork3 shared operators
Mimedx Group, Inc.BiotechnologySeed$8.2M$177.6Mnetwork3 shared operators
Credence MedSystems, Inc.Other Health CareSeries B$82.2M$71.9Msame sector · same stage
Wavetec Vision Systems IncOther Health CareSeries B$99.9M$64.1Msame sector · same stage
Benvenue Medical IncOther Health CareSeries B$69.1M$77.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Z-MRI Associates, LLCOther Health CarePre-Seed$4.6M89%
Wide-Bore MRI, LLCOther Health CarePre-Seed$3.1M88%
Optima MRI, LLCOther Health CarePre-Seed$3.1M87%
Translational Imaging Innovations, Inc.Other Health CarePre-Seed$14.1M87%
Imaging Network, LLCOther Health CarePre-Seed$191K86%
Best Imaging, LLCOther Health CarePre-Seed$1.2M85%
Research Imaging Company, LLCOther Health CareSeries C$678.9M85%
Great Lakes Imaging Associates, LLCOther Health CarePre-Seed$3.1M84%
Frequently asked
How much funding has Mri Interventions, Inc. raised?
Mri Interventions, Inc. has raised approximately $90.0M in disclosed capital across 13 recorded financing rounds, aggregated from public filings.
What is Mri Interventions, Inc.'s estimated valuation?
Provath's modeled valuation for Mri Interventions, Inc. is approximately $76.6M (modeled range $42.0M–$105.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Mri Interventions, Inc. at?
Mri Interventions, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Thu Nov 20.
What does Mri Interventions, Inc. do and where is it based?
Mri Interventions, Inc. operates in the Other Health Care sector, based in SOLANA BEACH.
Explore related

See where Mri Interventions, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Mri Interventions, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.